The Food and Drug Administration has approved a potential blockbuster drug from Johnson & Johnson that fights three forms of arthritis caused by immune-system deficiencies. ...more

April 24, 2009

Swiss pharmaceutical giant Roche agreed Thursday to pay $46.8 billion in cash to buy the 44 percent of California-based biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle between the companies. ...more

March 13, 2009

Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in a deal that gives Merck key new businesses, access to a promising pipeline of new products and the chance to cut costs by $3.5 billion more per year, including eliminating about 16,000 jobs. ...more

March 10, 2009

European study finds hormone therapy with radiation is effective against prostate cancer. ...more

December 15, 2008

Last warning: Asthma's rescue inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. ...more

December 2, 2008

WASHINGTON (AP) -- New claims for unemployment benefits jumped last week to their highest level in seven years due to the impact of a slowing economy and Hurricanes Ike and Gustav, the Labor Department reported Thursday. ...more

September 25, 2008

Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. ...more

August 22, 2008

At 41, Angela Jane Cowden is already starting her third career. "I was a chemist," says Cowden. She was a researcher who studied polymers, until the company she worked for changed hands. ...more

August 11, 2008

Here's a couch potato's dream: What if a drug could help you gain some of the benefits of exercise without working up a sweat? ...more

August 1, 2008

Merck & Co. plans to eliminate 1,200 U.S. sales jobs, a move that comes a week after federal regulators' surprise rejection of an experimental cholesterol drug heavily touted by the pharmaceutical company. ...more

May 7, 2008